These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 621612)

  • 1. Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial.
    Baluarte HJ; Hiner L; Gruskin AB
    J Pediatr; 1978 Feb; 92(2):295-8. PubMed ID: 621612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
    Grupe WE; Makker SP; Ingelfinger JR
    N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
    Bailey RR
    N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil in steroid-dependent nephrotic syndrome.
    Grupe WE
    J Pediatr; 1973 Apr; 82(4):598-606. PubMed ID: 4121460
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood.
    Williams SA; Makker SP; Ingelfinger JR; Grupe WE
    N Engl J Med; 1980 Apr; 302(17):929-33. PubMed ID: 6987521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Arbeitsgemeinschaft für Pädiatrische Nephrologie
    N Engl J Med; 1982 Feb; 306(8):451-4. PubMed ID: 7035953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology.
    Niaudet P
    Pediatr Nephrol; 1992 Jan; 6(1):1-3. PubMed ID: 1536727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorambucil therapy in childhood nephrotic syndrome.
    Wiggelinkhuizen J; McDonald R; van Dugteren GR
    S Afr Med J; 1979 Jun; 55(24):971-5. PubMed ID: 472947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of chlorambucil in frequently relapsing nephrotic syndrome in children (a preliminary report).
    Alatas H; Wirya IG; Tambunan T; Himawan S
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():222-8. PubMed ID: 342654
    [No Abstract]   [Full Text] [Related]  

  • 10. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E; Ksiazek J; Kryński J; Wyszyńska T
    Pediatr Pol; 1996 Aug; 71(8):679-83. PubMed ID: 8927471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of nephrotic syndrome in children (author's transl)].
    Schärer K
    Monatsschr Kinderheilkd; 1980 Nov; 128(11):685-8. PubMed ID: 6110172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A; Hodson E; Willis N; Craig J
    Cochrane Database Syst Rev; 2001; (4):CD002290. PubMed ID: 11687155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
    Chiu J; Drummond KN
    J Pediatr; 1974 Jun; 84(6):825-30. PubMed ID: 4855503
    [No Abstract]   [Full Text] [Related]  

  • 14. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children.
    Latta K; von Schnakenburg C; Ehrich JH
    Pediatr Nephrol; 2001 Mar; 16(3):271-82. PubMed ID: 11322378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
    Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R; Brem AS
    Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term assessment of chlorambucil in children with nephrotic syndrome who fail to respond adequately to corticosteroids.
    Pascual JF; Molina M; Lopez J
    Contrib Nephrol; 1981; 27():65-74. PubMed ID: 7285590
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie".
    Lancet; 1979 Feb; 1(8113):401-3. PubMed ID: 84259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
    Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
    Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
    Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.